ORDER ONLINE FOR INSTANT ACCESS        
Search:
homecourse contentcurrent volumeback volumessubscribecontact usfaq

AUDIO WILL STREAM THROUGH ANY DEVICE
« Previous IssueNext Issue »
NOTE: This issue is no longer available for CME credit. The AMA's 3-year time limit from when the issue was published has expired. You will be given a score but no credit.


All subscribers to ACOG UPDATE audio CDs will also have free access and ability to download the same program in MP3 format. They can also download a PDF file of the complete transcript with Pre- and Post-test Questions and a List of Supplementary Reading Materials.

Volume 39, Issue 3
Publication date: September 1, 2013
Expiration date: September 1, 2016

Cervical Cancer Screening and Treatment
Warner K. Huh, MD (Moderator)
Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology; Margaret Cameron Spain Endowed Chair in Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama

Walter K. Kinney, MD
Clinical Professor, Department of Obstetrics and Gynecology, University of California at Davis; Gynecologic Oncologist, The Permanente Medical Group, Sacramento, California

L. Stewart Massad Jr, MD
Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri

Learning Objectives
After completing this activity, the physician should be better able to:
1. Describe the reasons why the guideline revision was necessary.
2. Understand the concept of benchmarking risks to replicate current practice.
3. Select the optimal test modalities for following up women ages 21 years to 24 years and 25 years and older.
4. Recommend appropriate follow-up intervals for different screening test abnormalities.
5. Avoid overtesting at short intervals to permit low-grade disease resolution and reduce the likelihood of overtreatment.


Email Address

Password

Forgot my password
Not registered?
Click here to Sign-up
Listen, Learn and Earn